Demographics and clinical characteristics of the derivation and test cohorts.

1Nineteen subjects (18 survivors and 1 non-survivor) in the test cohort did not have available PRISM scores.
2p<0.05 vs. test cohort.
3p<0.05 vs. respective survivors.
4Refers to patients with immune suppression not related to cancer (for example, those receiving immune suppressive medication for solid organ or bone marrow transplantation, or those with a primary immune deficiency).